Home › Compare › TRDX vs JNJ

TRDX vs JNJ: Dividend Comparison 2026

TRDX yields 7407.41% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TRDX wins by $2885250170318598.50M in total portfolio value
10 years
TRDX
TRDX
● Live price
7407.41%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2885250170318598.50M
Annual income
$2,810,610,081,913,064,000,000.00
Full TRDX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — TRDX vs JNJ

📍 TRDX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTRDXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TRDX + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
TRDX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TRDX
Annual income on $10K today (after 15% tax)
$629,629.63/yr
After 10yr DRIP, annual income (after tax)
$2,389,018,569,626,104,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, TRDX beats the other by $2,389,018,569,626,104,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TRDX + JNJ for your $10,000?

TRDX: 50%JNJ: 50%
100% JNJ50/50100% TRDX
Portfolio after 10yr
$1442625085159299.25M
Annual income
$1,405,305,040,956,532,000,000.00/yr
Blended yield
97.41%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

TRDX
No analyst data
Altman Z
-372.6
Piotroski
2/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TRDX buys
0
JNJ buys
0
No recent congressional trades found for TRDX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTRDXJNJ
Forward yield7407.41% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$2885250170318598.50M ✓$20.0K
Annual income after 10y$2,810,610,081,913,064,000,000.00 ✓$827.78
Total dividends collected$2880254264436703.00M ✓$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: TRDX vs JNJ ($10,000, DRIP)

YearTRDX PortfolioTRDX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$751,441$740,740.74$10,676$355.77+$740.8K → TRDX
2$52,824,861$52,020,819.71$11,407$389.39+$52.81M → TRDX
3$3,474,247,022$3,417,724,420.68$12,198$426.53+$3474.23M → TRDX
4$213,793,034,542$210,075,590,227.87$13,056$467.62+$213793.02M → TRDX
5$12,310,364,652,217$12,081,606,105,257.41$13,987$513.12+$12310364.64M → TRDX
6$663,329,116,950,837$650,157,026,772,964.20$14,998$563.56+$663329116.94M → TRDX
7$33,450,813,926,342,110$32,741,051,771,204,716.00$16,098$619.52+$33450813926.33M → TRDX
8$1,578,865,388,564,817,400$1,543,073,017,663,631,600.00$17,295$681.69+$1578865388564.80M → TRDX
9$69,757,091,967,789,556,000$68,067,706,002,025,190,000.00$18,599$750.82+$69757091967789.54M → TRDX
10$2,885,250,170,318,598,700,000$2,810,610,081,913,064,000,000.00$20,022$827.78+$2885250170318598.50M → TRDX

TRDX vs JNJ: Complete Analysis 2026

TRDX — Stock

Trend Exploration, Inc engages in the supply of products for medical, dental, and veterinary communities. It offers acrylics, alloys, anesthetics, articulating products, burs and diamonds, cements, core materials, cosmetics, crowns, dentures, disposables, endodontics, evacuation products, filling products, finishing materials, infection control products, instruments, lab supplies, medicaments, orthodontics, pins and posts, preventive dentistry products, prophy products, retraction products, rubber dams, handpieces, surgical products, and X-ray products. The company was founded in 1987 and is based in Jericho, New York.

Full TRDX Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this TRDX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TRDX vs SCHDTRDX vs JEPITRDX vs OTRDX vs KOTRDX vs MAINTRDX vs ABBVTRDX vs MRKTRDX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.